$32.24B in CY2024 Part D spend36.8M claims · 8.4M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Apixaban used for?
Apixaban prevents blood clots by inhibiting factor Xa, prescribed for atrial fibrillation and venous thromboembolism.
Is there a generic for Apixaban?
Yes. 4 ANDAs filed at FDA, 2 generic manufacturers currently shipping.
How much does my plan pay for Apixaban?
Across 329 Part D plans, Apixaban averages $5.52/unit (NADAC). Lowest available: $5.51/unit. Highest in distribution: $5.53/unit.
Is Apixaban on the FDA shortage list?
No. Apixaban is not currently on the FDA Drug Shortage Database.
8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (8 approvals on file) · NADAC unit costs: CMS NADAC weekly file (6 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.